ETF Managers Group, LLC Incyte Corp Transaction History

ETF Managers Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $126,233 - $152,297	-1,717 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$63.56 - $88.17 $9,724 - $13,490	153 Added 9.78%	1,717 $148,000
Q4 2018 Feb 01, 2019	BUY	$58.5 - $69.94 $12,460 - $14,897	213 Added 15.77%	1,564 $99,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $8,768 - $10,540	142 Added 11.75%	1,351 $93,000
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $41,803 - $57,694	687 Added 131.61%	1,209 $65,000
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $5,315 - $6,462	64 Added 13.97%	522 $42,000
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $5,987 - $7,462	64 Added 16.24%	458 $46,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $43,005 - $54,478	394	394 $46,000

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.